Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $13.7500 (0.88%) ($13.7500 - $13.7500) on Wed. Sep. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.23% (three month average) | RSI | 43 | Latest Price | $13.7500(0.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.1% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) VT(32%) VUG(32%) XLK(32%) BLOK(29%) URA(29%) | Factors Impacting BCRX price | BCRX will decline at least -2.115% in a week (0% probabilities). VIXM(-15%) UUP(-14%) SMH(-11%) EDOC(-7%) VXX(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.115% (StdDev 4.23%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $14.25 | 5 Day Moving Average | $13.9(-1.08%) | 10 Day Moving Average | $14.09(-2.41%) | 20 Day Moving Average | $14.25(-3.51%) | To recent high | -7.2% | To recent low | 51.3% | Market Cap | $2.426b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |